Nordic Life Science 1
TOP STORIES BUSINESS NEW RE P OR T . the number o
f life science companies in the Stockholm-Uppsala region increased by almost 50%. This is stated in a report published by the Stockholm Science City Foundation on the 31 of March. Half of the employees within Sweden’s life science work in the region, which means 31,500 people at nearly 1,000 companies. The report also shows that half of Sweden’s patent applications originate from the region. The report also summarizes Mads Krogsgaard Thomsen, CEO, Novo Nordisk Foundation how the region compares globally. It is ranked as one of the most innovative regions in Europe, and only Silicon Valley can showcase a greater number of unicorns per capita state the authors of the report. C O V I D -19 is to help research“The duration of the COVID-19 ers worldwide identify and develop phase 2-ready antiviral drug candidates that target pandemic-threat viruses, including coronaviruses, paramyxoviruses, and orthomyxoviruses. By focusing on small molecule drugs that can be delivered orally and are cheaper and easier for patients to access than biologic drugs, PAD aims to help ensure the world is prepared to quickly develop and equitably deploy effective, accessible antiviral treatments next time a pandemic threat emerges. pandemic serves as a reminder that the world needs to invest in next-generation tools to combat emerging threats,” says Mads Krogsgaard Thomsen, CEO, Novo Nordisk Foundation. PAD funding partners will use a variety of models, including direct grants and requests for proposals (RFPs), within defined research topics. The focus of the first RFP will be henipavirus, a subfamily of paramyxovirus that includes Nipah virus. 10 NORDICLIFESCIENCE.ORG PHOTO NOVO NORDISK FOUNDATION